Timberline, Sage
Bhatt, Avni http://orcid.org/0000-0001-7727-9300
Sunderji, Sherzana
Tancredi, Daniel J. http://orcid.org/0000-0002-3884-7907
Lakshminrusimha, Satyan http://orcid.org/0000-0001-6098-2155
Siefkes, Heather http://orcid.org/0000-0003-3325-2821
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UL1 TR001860, KL2 TR001859)
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences
Children’s Miracle Network, University of California, Davis
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01 HD072929)
Article History
Received: 22 May 2023
Revised: 2 August 2023
Accepted: 21 August 2023
First Online: 25 August 2023
Competing interests
: Dr. Siefkes is the founder of a company called NeoPOSE that aims at improving critical congenital heart disease screening. Drs. Siefkes and Lakshminrusimha are listed as inventors on a patent application related to congenital heart disease screening. The authors declare no other competing interests.